The Year in Valvular Heart Disease

Journal of the American College of Cardiology

Volumn 43, Issue 3, 2004, Pages 491-504

  Rahimtoola, Shahbudin H ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXFENFLURAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE; LISINOPRIL; NATRIURETIC FACTOR; NITROPRUSSIDE SODIUM; PERGOLIDE MESILATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTERIAL PRESSURE; CALCIFIC AORTA STENOSIS; CRITICAL ILLNESS; CRYOPRESERVATION; DIALYSIS; DISEASE SEVERITY; ENDOCARDITIS; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RHEUMATIC HEART DISEASE; SYSTOLE; THROMBOSIS; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

EID: 0842330667     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.005     Document Type: Review

References (67)

1. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. First human case description. Circulation. 106:2002;3006-3008.
2. Boudjemline Y., Bonhoeffer P. Percutaneous valve insertion. A new approach? (letter) J Thorac Cardiovasc Surg. 125:2003;741-742.
3. Rajamannan N.M., Subramanian M., Springett M., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 105:2002;2660-2665.
4. Rajamannan N.M., Subramanian M., Rickard D., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 107:2003;2181-2184.
5. Drolet M.C., Arsenault M., Coult J. Experimental aortic valve stenosis in rabbit. J Am Coll Cardiol. 41:2003;1211-1217.
6. 1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis . Ann Thorac Surg. 75:2003;457-465.
7. Glader C.A., Birgander L.S., Söderberg S., et al. Lipoproetein (a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J. 24:2003;198-208.
8. Wallby L., Janerot-Sjöberg B., Steffensen T., Broquist M. T lymphocyte infiltration in non-rheumatic aortic stenosis A comparative descriptive study between tricuspid and bicuspid aortic valves . Heart. 88:2002;348-351.
9. Rajamannan N.M., Gersh B.G., Bonow R.O. Calcific aortic stenosis From bench to the bedside-emerging clinical and cellular concepts . Heart. 89:2003;801-805.
10. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in pressure-overloaded human heart. Structural deterioration and compensatory mechanisms. Circulation. 107:2003;984-991.
11. Garcia D., Dumesnil J.G., Durand L.-G., Kadem L., Pibarot P. Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon. Practical implications with regard to quantification of aortic stenosis severity. J Am Coll Cardiol. 41:2003;435-442.
12. Bermejo J, Odreman R, Feijoo J, Moreno MM, Gomez-Moreno P, Garcia-Fernandez MA. Clinical efficacy of Doppler-echocardographics indices of aortic valve stenosis: a comparative test-based analysis of outcome. J Am Coll Cardiol 2003;41:142-51.
13. Tobin J.R. Jr., Rahimtoola S.H., Blundell P.E., Swan H.J.C. Percentage of left ventricular stroke work loss. A simple hemodynamic concept for estimation of severity in valvular aortic stenosis. Circulation. 35:1967;868-879.
14. Warkentin T.E., Moore J.C., Morgan D.G. Gastrointestinal angiodysplasia and aortic stenosis. N Engl J Med. 347:2002;858-859.
15. Knot U.N., Navaro G.M., Popović Z.B., et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 348:2003;1756-1763.
16. Nishimura R.A., Grahtham J.A., Connolly H.M., Schaff H.V., Higano S.T., Holmes D.R. Jr. Low output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function. The clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 106:2002;809-813.
17. Malouf J.F., Enriquez-Sarano M., Pellikka P.A., et al. Severe pulmonary hypertension in patients with severe aortic stenosis Clinical profile and prognostic implications . J Am Coll Cardiol. 40:2002;789-795.
18. Rahimtoola S.H. Questions remain regarding patients with aortic stenosis and severe pulmonary hypertension. (letter) J Am Coll Cardiol. 41:2003;1847-1848.
19. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 86:1992;1099-1107.
20. Malouf J.F., Enriquez-Sarano M., Pellikka P.A., et al. Questions remain regarding patients with aortic stenosis and severe pulmonary hypertension (reply). J Am Coll Cardiol. 41:2003;1848.
21. Tarasoutchi F., Grinberg M., Spina G.S., et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 41:2003;1316-1324.
22. Mohan J.C., Patel A.R., Passey R., et al. Is mitral valve area flow-dependent in mitral stenosis? A dobutamine stress echocardiographic study. J Am Coll Cardiol. 40:2002;1809-1815.
23. Song J.M., Kang D.H., Song J.-K., et al. Outcome of significant functional tricuspid regurgitation after percutaneous mitral valvuloplasty. Am Heart J. 145:2003;371-376.
24. Silversides C.K., Colman J.M., Sermer S., Siu S.C. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 91:2003;1382-1385.
25. Choudhary S.K., Dhareshwar J., Govil A., Airan B., Kumar A.S. Open mitral commissurotomy in the current era Indications, technique, and result . Ann Thorac Surg. 75:2003;41-46.
26. Rahimtoola S.H., Durairaj A., Mehra A., Nuno I. Current evaluation and management of patients with mitral stenosis. Circulation. 106:2002;1183-1188.
27. Oral H., Sivasubramanian N., Dyke D.B., et al. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation. 107:2003;831-837.
28. Sutton T.M., Stewart R.A.H., Gerber I.L., et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 41:2003;2280-2287.
29. Mehta R.H., Supiano M.A., Oral H., et al. Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J. 145:2003;1078-1085.
30. Nemoto S., Hamawaki M., Freitas D.G., Carabello B.A. Differential effects of the angiotension-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol. 40:2002;149-154.
31. Perry GJ, Wei C-C, Hankes GH, et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 2002;39:1374-9.
32. Gaasch W.H., Aurigemma G.P. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation (editorial). J Am Coll Cardiol. 39:2002;1380-1383.
33. Otto C.M. Timing of surgery in mitral regurgitation. Heart. 89:2003;100-105.
34. Braumberger E., Deloche A., Berrebi A., et al. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in non-rheumatic mitral valve insufficiency. Circulation. 104:(Suppl I):2001;1-11.
35. Chauvand S., Fuzellier J.F., Berrebi A., Deloche A., Fabiani J.N., Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation. 104:(Suppl I):2001;12-15.
36. Rahimtoola S.H. Lessons learned about the determinants of the results of valve surgery. Circulation. 78:1988;1503-1507.
37. Carpentier A., Chauvand S., Fabiani J., et al. Reconstructive surgery of mitral incompetence Ten-year appraisal . J Thorac Cardiovasc Surg. 79:1980;338-348.
38. Carpentier A. Cardiac valve surgery - the "French correction" J Thorac Cardiovasc Surg. 86:1983;323-337.
39. Savage E.B., Ferguson T.B. Jr., Di Sesa V.J. Use of mitral valve repair Analysis of contemporary united states experience reported to the society of thoracic surgeons national cardiac database . Ann Thorac Surg. 75:2003;820-825.
40. Carpentier A. Valve repair: the final frontier. Presented at the ACC Annual Scientific Sessions, Chicago, IL, March 31, 2003.
41. Flameng W., Herigers P., Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 107:2003;1609-1613.
42. Schachner T., Bonatti J., Balogh D., et al. Aortic valve replacement in the conscious patient under regional anesthesia without endotracheal intubation. J Thorac Cardiovasc Surg. 125:2003;1526-1527.
43. Hoerstrup S.P., Kadner A., Melnitchouk S., et al. Tissue engineering of a functional trileaflet heart valves from human marrow stromal cells. Circulation. 106:(Suppl I):2002;143-150.
44. Cebotari S., Mertsching H., Kallenbach K., et al. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation. 106:(Suppl I):2002;63-68.
45. Bertipaglia B., Ortolani F., Petrelli L., et al. Cell cellularization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells The vesalio project (vitalitate exornatum succedaneum aorticum labore ingenioso obtenibitur) . Ann Thorac Surg. 75:2003;1274-1282.
46. Oxenham H., Bloomfield P., Wheatly D.J., et al. Twenty-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 89:2003;715-721.
47. Hammermeister K.E., Sethi G.K., Henderson W.G., Grover F.L., Oprian C., Rahimtoola S.H. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve Final report of the veterans affairs randomized trial . J Am Coll Cardiol. 36:2000;1152-1158.
48. Roudat R., Lafitte S., Roudat M.F., et al. Fibronolysis of mechanical prosthetic valve thrombosis. A single-center study of 127 cases. J Am Coll Cardiol. 41:2003;653-658.
49. Hurrell D.G., Schaff H.V., Tajik A.J. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin Proc. 71:1996;605-613.
50. Lengyel M., Fuster V., Keltai M., et al. Guidelines for management of left-sided prosthetic valve thrombosis A role for thrombolytic therapy: consensus conference on prosthetic valve thrombosis . J Am Coll Cardiol. 30:1997;1521-1526.
51. Edwards M.B., Taylor K.M. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg. 75:2003;830-834.
52. Bacchetta M.D., Ko W., Girardi L.N., et al. Outcomes of cardiac surgery in nonagenarians A 10-year experience . Ann Thorac Surg. 75:2003;1215-1220.
53. Vitale N., Clark S.C., Ramsden A., Hasan A., Hilton C.J., Holden M.P. Clinical and hemodynamic evaluation of small perimount aortic valves in patients aged 75 years or older. Ann Thorac Surg. 75:2003;35-40.
54. Becassis P., Hayot M., Frapier J.-M., et al. Post-operative exercise tolerance after aortic valve replacement by small-size prosthesis. Functional consequence of small-size aortic prosthesis. J Am Coll Cardiol. 36:2000;871-877.
55. Edwards F.H., Petersen E.D., Coombs L.P., et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 37:2001;885-892.
56. Herzog C.A., Ma J.Z., Collins A.J. Long-term survival of dialysis patients in the United States with prosthetic heart valves. Should ACC/AHA Practice Guidelines on valve selection be modified? Circulation. 105:2002;1336-1341.
57. Bonow R.O., Carabello B., DeLeon A.C. Jr., et al. ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 32:1998;1486-1588.
58. Byrne J.G., Karavas A.N., Mihaljevic T., Rawn J.D., Aranki S.F., Cohn L.H. Role of cryopreserved homograft in isolated elective aortic valve replacement. Am J Cardiol. 91:2003;616-619.
59. Palka P., Havrocks S., Lange A., Burstow D., O'Brien M.F. Primary aortic valve replacement with cryopreserved aortic allograft An echocardiogaphic follow-up study of 507 patients . Circulation. 105:2002;61-66.
60. Grunkemeier G.L., Bodnar E. Cooperative assessment of bioprostheses durability in the aortic position. J Heart Valve Dis. 4:1995;49-55.
61. Rahimtoola S.H. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 41:2003;893-904.
62. Hung L., Rahimtoola S.H. Prosthetic heart valves and pregnancy. Circulation. 107:2003;1240-1246.
63. Pritchett A.M., Morrison J.F., Edwards W.D., Schaff H.V., Connolly H.M., Espinosa R.E. Valvular heart disease in patients taking pergolide. Mayo Clin Proc. 77:2002;1280-1286.
64. Connolly H.M., Crary J.L., McGoon M.D., et al. Valvular heart disease associated with fenfluramine-phenteramine. N Engl J Med. 337:1997;581-588.
65. Deveras R.A.E., Kessler C.M. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med. 137:2002;884-888.
66. Casselman F.P., Slycke S.V., Dom H., Lambrechts D.L., Vermenlen Y., Vanermen H. Endoscopic mitral valve repair Feasible, reproducible and durable . J Thorac Cardiovasc Surg. 125:2003;273-282.
67. Hasdai D., Lev E.I., Behar S., et al. Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart Lessons from the euro-heart survey of acute coronary syndromes . Eur Heart J. 24:2003;623-629.